High-output fistula

Clinics in Colon and Rectal Surgery

Volumn 17, Issue 2, 2004, Pages 89-98

  Arebi, Naila ^a   Forbes, Alastair ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

Author keywords

High output fistulae; Nutrition; Pathophysiology; Somatostatin

Indexed keywords

FIBRIN GLUE; OCTREOTIDE; SOMATOSTATIN 14;

BARIUM ENEMA; COLORECTAL SURGERY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ECHOGRAPHY; ENDOSCOPIC THERAPY; ENTEROCUTANEOUS FISTULA; FISTULA; FISTULOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALNUTRITION; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; REVIEW; SKIN CARE; TREATMENT OUTCOME; ULTRASOUND; WOUND CARE; WOUND CLOSURE;

EID: 2942529354     PISSN: 15310043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-828655     Document Type: Review

References (58)

1. Edmunds LH Jr, Williams GM, Welch CE. External fistulas arising from the gastro-intestinal tract. Ann Surg 1960;152:445-471
2. Rocchio MA, Cha CJ, Haas KF, Randall HT. Use of chemically defined diets in the management of patients with high output gastrointestinal cutaneous fistulas. Am J Surg 1974;127:148-156
3. Deitel M. Nutritional management of external gastrointestinal fistulas. Can J Surg 1976;19:505-509
4. Sitges-Serra A, Jaurrieta E, Sitges-Creus A. Management of postoperative enterocutaneous fistulas: the roles of parenteral nutrition and surgery. Br J Surg 1982;69:147-150
5. McIntyre PB, Ritchie JK, Hawley PR. Management of enterocutaneous fistulas: a review of 132 cases. Br J Surg 1984;71:293-296
6. Athanassiades S, Notis P, Tountas C. Fistulas of the gastrointestinal tract. Experience with eighty-one cases. Am J Surg 1975;130:26-28
7. Chamberlain RS, Kaufman HL, Danforth DN. Enterocutaneous fistula in cancer patients: etiology, management, outcome, and impact on further treatment. Am Surg 1998;64:1204-1211
8. + secretion and effect of acetazolamide in humans. Am J Physiol 1991;261(2 Pt 1):G320-G326
9. Read NW, Cooper K, Fordtran JS. Effect of modified sham feeding on jejunal transport and pancreatic and biliary secretion in man. Am J Physiol 1978;234:E417-E420
10. Kidd M, Modlin IM, Tang LH. Gastrin and the enterochromaffin-like cell: an acid update. Dig Surg 1998;15:209-217
11. Drucker DJ, Erlich P, Asa SL, Brubaker PL. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA 1996;93:7911-7916
12. Jeppesen PB, Hartmann B, Thulesen J, et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 2001;120:806-815
13. Alexander ES, Weinberg S, Clark RA, Belkin RD. Fistulas and sinus tracts: radiographic evaluation, management, and outcome. Gastrointest Radiol 1982;7:135-140
14. Cresci GA, Martindale RG. Metabolic and nutritional management of a patient with multiple enterocutaneous fistulas. Nutrition 1997;13:446-448
15. Gasche C, Moser G, Turetschek K, Schober E, Moeschl P, Oberhuber G. Transabdominal bowel sonography for the detection of intestinal complications in Crohn's disease. Gut 1999;44:112-117
16. Maconi G, Parente F, Porro GB. Hydrogen peroxide enhanced ultrasound-fistulography in the assessment of enterocutaneous fistulas complicating Crohn's disease. Gut 1999;45:874-878
17. Maconi G, Sampietro GM, Parente F, et al. Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn's disease: a prospective comparative study. Am J Gastroenterol 2003;98:1545-1555
18. Orel SG, Rubesin SE, Jones B, Fishman EK, Bayless TM, Siegelman SS. Computed tomography vs barium studies in the acutely symptomatic patient with Crohn disease. J Comput Assist Tomogr 1987;11:1009-1016
19. Jobling C, Halligan S, Bartram C. The use of non-ionic water-soluble contrast agents for small bowel follow-through examination. Eur Radiol 1999;9:706-710
20. Potthast S, Rieber A, Von Tirpitz C, Wruk D, Adler G, Brambs HJ. Ultrasound and magnetic resonance imaging in Crohn's disease: a comparison. Eur Radiol 2002;12:1416-1422
21. Rieber A, Nussle K, Reinshagen M, Brambs HJ, Gabelmann A. MRI of the abdomen with positive oral contrast agents for the diagnosis of inflammatory small bowel disease. Abdom Imaging 2002;27:394-399
22. Koelbel G, Schmiedl U, Majer MC, et al. Diagnosis of fistulae and sinus tracts in patients with Crohn disease: value of MR imaging. AJR Am J Roentgenol 1989;152:999-1003
23. Bell SJ, Halligan S, Windsor AC, Williams AB, Wiesel P, Kamm MA. Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging. Aliment Pharmacol Ther 2003;17:387-393
24. Dombrowski SR, Mirtallo JM. Drug therapy and nutritional management of patients with gastrointestinal fistulas. Clin Pharm 1984;3:264-272
25. Bruley des Varennes S, Levy P, Lartigue S, Dellatolas F, Lemaire M, Galmiche JP. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers. Aliment Pharmacol Ther 1994;8:309-314
26. Londong W, Londong V, Cederberg C, Steffen H. Dose-response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release. Gastroenterology 1983;85:1373-1378
27. Katz PO, Hatlebakk JG, Castell DO. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole. Aliment Pharmacol Ther 2000;14:709-714
28. Deitel M. Nutritional management of external gastrointestinal fistulas. Can J Surg 1976;19:505-509
29. Rose D, Yarborough MF, Canizaro PC, Lowry SF. One hundred and fourteen fistulas of the gastrointestinal tract treated with total parenteral nutrition. Surg Gynecol Obstet 1986;163:345-350
30. Rocchio MA, Cha CJ, Haas KF, Randall HT. Use of chemically defined diets in the management of patients with high output gastrointestinal cutaneous fistulas. Am J Surg 1974;127:148-156
31. Levy E, Frileux P, Cugnenc PH, Honiger J, Ollivier JM, Parc R. High-output external fistulae of the small bowel: management with continuous enteral nutrition. Br J Surg 1989;76:676-679
32. Sitges-Serra A, Jaurrieta E, Sitges-Creus A. Management of postoperative enterocutaneous fistulas: the roles of parenteral nutrition and surgery. Br J Surg 1982;69:147-150
33. Zera RT, Bubrick MP, Sternquist JC, Hitchcock CR. Enterocutaneous fistulas. Effects of total parenteral nutrition and surgery. Dis Colon Rectum 1983;26:109-112
34. McIntyre PB, Ritchie JK, Hawley PR. Management of enterocutaneous fistulas: a review of 132 cases. Br J Surg 1984;71:293-296
35. Wolfe BM, Keltner RM, Willman VL. Intestinal fistula output in regular, elemental, and intravenous alimentation. Am J Surg 1972;124:803-806
36. Chamberlain RS, Kaufman HL, Danforth DN. Enterocutaneous fistula in cancer patients: etiology, management, outcome, and impact on further treatment. Am Surg 1998;64:1204-1211
37. Frost S. Stoma care: managing high-output fistulas. Nurs Stand 1991;5:25-27
38. Burch J. The nursing care of a patient with enterocutaneous faecal fistulae. Br J Nurs 2003;12:736-740
39. Lichtenstein GR. Treatment of fistulizing Crohn's disease. Gastroenterology 2000;119:1132-1147
40. Walsh JH. Gastrointestinal hormones. In: Johnson LR eds. Physiology of the Gastrointestinal Tract. New York: Raven Press; 1994:1-128
41. Pederzoli P, Bassi C, Falconi M, Albrigo R, Vantini I, Micciolo R. Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion of somatostatin, glucagon or calcitonin. Surg Gynecol Obstet 1986;163:428-432
42. Torres AJ, Landa JI, Moreno-Azcoita M, et al. Somatostatin in the management of gastrointestinal fistulas. A multicenter trial. Arch Surg 1992;127:97-99
43. Planas M, Porta I, Angles R, Baena JA, Serra J, Padro JB. [Somatostatin and/or total parenteral nutrition for the treatment of intestinal fistulas]. Rev Esp Enferm Dig 1990;78:345-347
44. Torres AJ, Landa JI, Moreno-Azcoita M, et al. Somatostatin in the management of gastrointestinal fistulas. A multicenter trial. Arch Surg 1992;127(1):97-99
45. Nubiola-Calonge P, Badia JM, Sancho J, Gil MJ, Segura M, Sitges-Serra A. Blind evaluation of the effect of octreotide (SMS 201-995), a somatostatin analogue, on small-bowel fistula output. Lancet 1987;2:672-674
46. Scott NA, Finnegan S, Irving MH. Octreotide and gastrointestinal fistulae. Digestion 1990;45(Suppl 1):XS66-70 discussion 70-71
47. Sancho JJ, di Costanzo J, Nubiola P, et al. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula. Br J Surg 1995;82:638-641
48. Hernandez-Aranda JC, Gallo-Chico B, Flores-Ramirez LA, Avalos-Huante R, Magos-Vazquez FJ, Ramirez-Barba EJ. [Treatment of enterocutaneous fistula with or without octreotide and parenteral nutrition]. Nutr Hosp 1996;11:226-229
49. Hesse U, Ysebaert D, de Hemptinne B. Role of somatostatin-14 and its analogues in the management of gastrointestinal fistulae: clinical data. Gut 2001;49(Suppl 4):iv11-iv21
50. di Costanzo J, Cano N, Martin J, et al. Treatment of external gastrointestinal fistulas by a combination of total parenteral nutrition and somatostatin. JPEN J Parenter Enteral Nutr 1987;11:465-470
51. Ysebaert D, Van Hee R, Hubens G, Vaneerdeweg W, Eyskens E. Management of digestive fistulas. Scand J Gastroenterol Suppl 1994;207:42-44
52. Hild P, Dobroschke J, Henneking K, Rieck B. Treatment of enterocutaneous fistulas with somatostatin. Lancet 1986;2:626
53. Nubiola P, Badia JM, Martinez-Rodenas F, et al. Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201-995. Ann Surg 1989;210:56-58
54. Barnes SM, Kontny BG, Prinz RA. Somatostadn analog treatment of pancreatic fistulas. Int J Pancreatol 1993;14:181-188
55. O'Keefe SJ, Haymond MW, Bennet WM, Oswald B, Nelson DK, Shorter RG. Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies. Gastroenterology 1994;107:379-388
56. Berry SM, Fischer JE. Classification and pathophysiology of enterocutaneous fistulas. Surg Clin North Am 1996;76:1009-1018
57. Athanassiades S, Notis P, Tountas C. Fistulas of the gastrointestinal tract. Experience with eighty-one cases. Am J Surg 1975;130:26-28
58. Rabago LR, Ventosa N, Castro JL, Marco J, Herrera N, Gea F. Endoscopic treatment of postoperative fistulas resistant to conservative management using biological fibrin glue. Endoscopy 2002;34:632-638